HNI CORP quarterly report, Q3 FY2022

HNI Corporation — Q3 2022 Form 10-Q Summary

Period note: The request metadata says 2021 Q3, but the supplied filing is for the quarter ended October 1, 2022, with comparisons to October 2, 2021. This summary covers the filing provided.

Business context and reporting period

HNI designs and sells workplace furnishings and residential building products, reported in two segments. The filing covers the third quarter and first nine months of fiscal 2022. In July, HNI sold its China- and Hong Kong-based Lamex office furniture business. It also acquired residential building products businesses, including Dickerson Hearth Products in June.

Financial performance

MetricQ3 2022Q3 2021Nine months 2022Nine months 2021
Net sales$598.8 million$586.7 million$1,792.9 million$1,581.5 million
Gross profit / margin$209.5 million / 35.0%$195.4 million / 33.3%$627.0 million / 35.0%$563.2 million / 35.6%
Operating income$81.9 million$26.2 million$132.2 million$73.5 million
Net income attributable to HNI$63.1 million$19.2 million$107.6 million$51.6 million
Diluted EPS$1.51$0.43$2.54$1.17
Operating cash flowNot presented quarterlyNot presented quarterly$33.9 million$88.5 million

Q3 reported operating income includes a $50.6 million pre-tax gain on the Lamex sale. Excluding that gain, operating income was $31.3 million, or about 5.2% of sales, compared with $26.2 million, or 4.5%, a year earlier. Q3 reported operating margin was 13.7%; net margin was 10.5%. Nine-month reported operating margin was 7.4%, including the sale gain, and net margin was 6.0%.

Q3 workplace furnishings sales declined 4.6% to $375.2 million; segment operating profit was $5.6 million, or 1.5% of sales. Residential building products sales rose 15.5% to $223.6 million; segment operating profit was $39.6 million, or 17.7% of sales. For nine months, sales rose 9.1% in workplace furnishings and 21.5% in residential building products.

Liquidity, debt and capital

  • At October 1, 2022, cash and cash equivalents were $21.1 million; short-term investments were $2.0 million. Total debt was $200.8 million, including $100 million drawn on the revolving credit facility. Cash less total debt was approximately negative $179.7 million.
  • Current assets were $540.0 million and current liabilities were $460.4 million, a current ratio of approximately 1.17. Inventory was $222.2 million, up from $181.6 million at January 1, 2022.
  • The amended revolving facility provides $400 million of capacity and matures in June 2027; $300 million remained available. HNI reported covenant compliance and expected to remain compliant over the next twelve months. Variable-rate debt was $100 million; fixed-rate notes totaled $100 million and mature in 2025 and 2028.
  • Nine-month capital expenditures, including capitalized software, were $48.7 million. HNI paid $39.9 million in dividends and reported $65.2 million of share repurchases in cash flows for the period. Cash declined from $52.3 million at the start of the year to $21.1 million.

Material changes and management commentary

  • Q3 sales grew 2.1%; the residential segment’s growth and price realization offset lower workplace furnishings sales. Acquisitions added $11.2 million to Q3 sales, while the Lamex divestiture reduced sales by $17.9 million.
  • Management attributed improved Q3 gross margin to better price-cost and product mix, partly offset by lower workplace volume, reduced productivity and operational investments. Nine-month gross margin fell 60 basis points, primarily due to lower productivity.
  • Q3 results included $9.1 million of one-time restructuring and cost-reduction charges. HNI also recorded a $1.0 million impairment of an equity investment in the first nine months.
  • The nine-month effective tax rate was 14.5%, versus 24.2% in 2021, largely because the Lamex transaction generated tax benefits. Q3 rates were 20.7% and 21.5%, respectively.
  • Operating cash flow fell year over year, which management attributed mainly to working-capital timing, earlier inventory purchases and inflationary cost pressures. Net investing cash flow included $71.4 million of proceeds from the Lamex sale.
  • Management initiated company-wide cost reductions in Q3, estimating annual savings of $30 million once fully mature in 2023. Full-year 2022 capital expenditures were expected to be approximately $70–$75 million.
  • Management cited near-term uncertainty from macroeconomic conditions, labor availability, supply-chain capacity and cost inflation, while remaining optimistic about long-term market prospects. It said cash, operating cash flow and available borrowing capacity should fund operations and needs for at least twelve months.

Risks, commitments and contingencies

Risk factors include inflation, supply-chain disruption, labor shortages, demand for office furniture and housing, raw-material costs, competition, international operations, cybersecurity and financing restrictions. HNI disclosed approximately $12 million of dealer borrowing guarantees for which it had accrued no liability because payment was not considered probable. It also has approximately $27 million of letters of credit and surety bonds. A new facility lease entails about $61 million of minimum payments over approximately 15 years, with payments expected to begin in 2023. Management said ordinary-course litigation, environmental, tax and other claims were not expected to materially affect results or financial condition.

Important facts for investors to verify

  • Confirm the intended reporting period: the supplied filing is Q3 2022, not Q3 2021.
  • Assess earnings excluding the $50.6 million Lamex gain and related tax benefits, as well as the $9.1 million of Q3 one-time charges.
  • Track workplace furnishings demand, residential segment growth and margins, and whether announced cost savings are achieved.
  • Monitor working-capital needs, inventory, operating cash generation, variable-rate borrowing costs and covenant headroom.
  • Review the timing and cash impact of the new facility lease, dealer guarantees and remaining share-repurchase authorization.